Systematic Review and Meta-Analysis of the Efficacy and Safety of Perampanel in the Treatment of Partial-Onset Epilepsy

INTRODUCTION: Perampanel is a first-in-class antiepileptic drug approved for adjunctive treatment of partial-onset seizure in patients aged 12 years or older. Published randomised controlled trials (RCTs) had small sample sizes, and meta-analyses have included too few studies to draw conclusive resu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Warrington W. Q., Sing, C. W., He, Ying, Worsley, Alan J., Wong, Ian C. K., Chan, Esther W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784051/
https://www.ncbi.nlm.nih.gov/pubmed/23918722
http://dx.doi.org/10.1007/s40263-013-0091-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784051/
https://www.ncbi.nlm.nih.gov/pubmed/23918722
http://dx.doi.org/10.1007/s40263-013-0091-9

Ejemplares similares